Bridger, LLC
Bridger, LLC is a company.
Active
Updated: ·
Financial History
Total Raised
N/A
Valuation
N/A
Leadership Team
Key people at Bridger, LLC.
Bridger, LLC is a company.
Key people at Bridger, LLC.
Key people at Bridger, LLC.
Bridger Management, LLC (also referred to as Bridger Capital) is a New York City-based hedge fund manager founded in July 2000 by Roberto Mignone, focused on achieving long-term, superior risk-adjusted total returns through investments primarily in public equities.[1][4][5] Its mission centers on generating risk-adjusted capital growth, with a portfolio as of mid-2025 including top holdings like Morgan Stanley (12.77%), Uber (7.03%), Amazon (6.92%), Teva Pharmaceutical (6.87%), and Pfizer (5.84%), reflecting a strategy tilted toward financials, tech, and pharmaceuticals.[3] The firm manages around $170 million in 13F-reported assets, with moderate turnover (41.18%) and a history of holding top positions for about 6 quarters on average.[3]
While distinct from entities like Bridger Growth Partners (a Georgia family office investing in consumer brands) or Bridger Investment Partners (focused on residential loans), Bridger Management stands out in the hedge fund space for its longevity and focus on concentrated, long-term public market bets rather than startups.[1][2][7]
Bridger Management, LLC was formally organized as a Delaware limited liability company on April 25, 2000, with operations starting in July under founder and manager Roberto Mignone.[1][3] Based at 90 Park Avenue in New York, the firm emerged during the dot-com era to pursue hedge fund strategies emphasizing long-term capital appreciation.[4] Mignone, a key figure with a background in finance, has steered its evolution from inception through market cycles, maintaining a focus on public securities without major pivots into private markets or venture.[1][5]
Little public detail exists on early milestones, but its persistence over 25 years—navigating 2008, COVID volatility, and recent rate shifts—highlights disciplined growth, culminating in a 2025 portfolio down to $170 million from $201 million prior, amid active trading (e.g., new buys and sells in pharma and tech stocks).[3][4]
Bridger Management rides the convergence of tech-enabled disruption in finance, mobility, and healthcare—evident in holdings like Uber and Amazon—amid market forces like AI-driven efficiencies and post-pandemic digital acceleration.[3] Its timing aligns with a maturing public tech ecosystem, where hedge funds arbitrage growth stocks post-IPO (e.g., Spotify, Vertex in recent activity), influencing liquidity without direct startup involvement.[3] Unlike VC firms fueling early-stage innovation, Bridger provides scale capital to proven tech leaders, subtly shaping ecosystem maturity by rewarding scalable models over speculative bets.[1][3]
Bridger's concentrated public equity approach positions it well for 2026 trends like AI integration in pharma (e.g., Alnylam, SpringWorks sells) and fintech resilience (Morgan Stanley overweight), potentially rebounding from recent portfolio contraction via selective adds in undervalued tech/health names.[3] Evolving regulations on hedge funds and rising retail access to markets could amplify its influence, though competition from passive ETFs may pressure active managers—expect tighter focus on alpha-generating niches. As a 25-year survivor, Bridger exemplifies enduring hedge fund grit in a tech-saturated landscape, delivering the risk-adjusted returns that define its New York roots.[1][4]
